These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 18827052

  • 1. Autoimmune-mediated atherothrombosis.
    Matsuura E, Lopez LR.
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 4. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Nov; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 5. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 6. Atherosclerosis in autoimmune diseases.
    Matsuura E, Kobayashi K, Lopez LR.
    Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
    [Abstract] [Full Text] [Related]

  • 7. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
    Matsuura E, Kobayashi K, Matsunami Y, Lopez LR.
    Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
    [Abstract] [Full Text] [Related]

  • 8. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I.
    Lupus; 2006 May; 15(2):80-6. PubMed ID: 16539278
    [Abstract] [Full Text] [Related]

  • 9. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M, Andrejević S, Bonaci-Nikolić B, Obradović I, Miljić P, Majkić-Singh N.
    Clin Lab; 2005 May; 51(5-6):279-83. PubMed ID: 15991801
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 May; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 11. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T, Yasuda T, Matsuura E.
    J Autoimmun; 2007 May; 29(2-3):164-73. PubMed ID: 17826950
    [Abstract] [Full Text] [Related]

  • 12. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E.
    Lupus; 2007 May; 16(12):929-38. PubMed ID: 18042586
    [Abstract] [Full Text] [Related]

  • 13. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 14. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y.
    Lupus; 2005 Mar; 14(9):736-41. PubMed ID: 16218478
    [Abstract] [Full Text] [Related]

  • 15. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K, Lopez LR, Matsuura E.
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [Abstract] [Full Text] [Related]

  • 16. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR, Hurley BL, Simpson DF, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [Abstract] [Full Text] [Related]

  • 17. Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmune-mediated atherosclerosis.
    Lopez LR, Buckner TR, Hurley BL, Kobayashi K, Matsuura E.
    Ann N Y Acad Sci; 2007 Aug; 1109():303-10. PubMed ID: 17785319
    [Abstract] [Full Text] [Related]

  • 18. Peripheral vascular disease in antiphospholipid syndrome.
    Vlachoyiannopoulos PG, Samarkos M.
    Thromb Res; 2004 Aug; 114(5-6):509-19. PubMed ID: 15507285
    [Abstract] [Full Text] [Related]

  • 19. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
    Matsuura E, Lopez LR.
    Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
    [Abstract] [Full Text] [Related]

  • 20. Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome.
    Laczik R, Szodoray P, Veres K, Lakos G, Sipka S, Szegedi G, Soltész P.
    Autoimmunity; 2010 Jun; 43(4):334-9. PubMed ID: 20187701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.